STAAR Surgical Company

STAA Healthcare Medical Instruments & Supplies

In the quarter to June 2026, revenue grew 111.0%, EPS grew 147.1% and free cash flow grew 166.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

21.27 0.99 −4.45%
Market cap
$1.1B
P/E
304×
Fwd P/E
103×
Dividend yield
—
F-score
2/9
Altman Z
6.44
Beneish M
−3.29
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 409.86
P/S ratio
5.78 4.78 3.21 4.25
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
500.05 (292.42) (43.02) 73.32
P/B ratio
3.77 3.33 2.65 3.95
Price to Tangible BV
3.79 3.34 2.66 3.97
EV/Sales
4.95 4.13 2.76 3.81
EV/EBITDA
0.00 0.00 0.00 55.79
EV/Operating CF
(38.45) (28.91) (15.95) (397.73)
EV/FCF
(28.80) (24.65) (14.54) (189.32)
Quick Ratio
4.10 3.47 4.02 3.81
Current Ratio
5.21 4.55 5.12 4.66
Net Debt/EBITDA
(9.46) 7.54 (13.33) (13.53)
Debt/Assets
0.00% 7.19% 6.91% 0.00%
Debt/Equity
0.00 0.09 0.09 0.00
Asset Turnover
0.46 0.50 0.64 0.74
Operating CF/Net income
0.30 0.21 (4.17) 2.44
Capex/Depreciation
(0.47) (0.74) (0.22) (0.15)
Research and Development Expense of Revenue
9.72% 15.99% 10.61% 10.63%
Selling, General and Administrative Expense of Revenue
46.68% 78.60% 44.41% 53.12%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
8.61% 14.90% 5.16% 7.01%
Graham Net Nets
0.16 0.18 0.23 0.16
Graham Number
0.00 0.00 0.00 3.38
Earnings Yield
(7.26%) (7.06%) (2.30%) 0.24%
Free Cash Flow Yield
(2.97%) (3.51%) (5.90%) (0.47%)
Revenue per Share
1.91 1.17 1.87 1.86
Operating CF per Share
0.05 (0.08) (0.43) 0.39
Capex per Share
(0.02) (0.03) (0.01) (0.01)
Free Cash Flow per Share
0.04 (0.11) (0.44) 0.38
Cash per Share
3.88 3.78 3.28 3.61
Shareholders Equity per Share
7.13 6.94 7.06 7.26
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
7.13 6.94 7.06 7.26
Free Cash Flow
1.78 (5.59) (22.14) 19.20
Working Capital
259.57 243.04 251.40 268.96
Capital Expenditures
(0.88) (1.68) (0.44) (0.49)
Net Current Asset Value
218.63 204.05 213.65 232.55
EV/EBIT
0.00 0.00 0.00 94.19
Capex to Sales
0.01 0.03 0.00 0.01
Price to Operating Income
0.00 0.00 0.00 105.13
Other line items
Average Receivables
82.31 63.98 60.56 66.46
Average Payables
11.94 14.14 10.08 12.91
Average Inventory
46.83 49.40 48.96 49.97
Average Assets
496.98 480.60 454.24 456.49
Average Common Equity
390.95 370.76 351.17 350.99

Fold the line items

Columns are period end dates